Cargando…

Current Advancements and Limitations of Gene Editing in Orphan Crops

Gene editing provides precise, heritable genome mutagenesis without permanent transgenesis, and has been widely demonstrated and applied in planta. In the past decade, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) has revolutionized the applicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Venezia, Matthew, Creasey Krainer, Kate M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493294/
https://www.ncbi.nlm.nih.gov/pubmed/34630494
http://dx.doi.org/10.3389/fpls.2021.742932
_version_ 1784579092633354240
author Venezia, Matthew
Creasey Krainer, Kate M.
author_facet Venezia, Matthew
Creasey Krainer, Kate M.
author_sort Venezia, Matthew
collection PubMed
description Gene editing provides precise, heritable genome mutagenesis without permanent transgenesis, and has been widely demonstrated and applied in planta. In the past decade, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) has revolutionized the application of gene editing in crops, with mechanistic advances expanding its potential, including prime editing and base editing. To date, CRISPR/Cas has been utilized in over a dozen orphan crops with diverse genetic backgrounds, leading to novel alleles and beneficial phenotypes for breeders, growers, and consumers. In conjunction with the adoption of science-based regulatory practices, there is potential for CRISPR/Cas-mediated gene editing in orphan crop improvement programs to solve a plethora of agricultural problems, especially impacting developing countries. Genome sequencing has progressed, becoming more affordable and applicable to orphan crops. Open-access resources allow for target gene identification and guide RNA (gRNA) design and evaluation, with modular cloning systems and enzyme screening methods providing experimental feasibility. While the genomic and mechanistic limitations are being overcome, crop transformation and regeneration continue to be the bottleneck for gene editing applications. International collaboration between all stakeholders involved in crop improvement is vital to provide equitable access and bridge the scientific gap between the world’s most economically important crops and the most under-researched crops. This review describes the mechanisms and workflow of CRISPR/Cas in planta and addresses the challenges, current applications, and future prospects in orphan crops.
format Online
Article
Text
id pubmed-8493294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84932942021-10-07 Current Advancements and Limitations of Gene Editing in Orphan Crops Venezia, Matthew Creasey Krainer, Kate M. Front Plant Sci Plant Science Gene editing provides precise, heritable genome mutagenesis without permanent transgenesis, and has been widely demonstrated and applied in planta. In the past decade, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) has revolutionized the application of gene editing in crops, with mechanistic advances expanding its potential, including prime editing and base editing. To date, CRISPR/Cas has been utilized in over a dozen orphan crops with diverse genetic backgrounds, leading to novel alleles and beneficial phenotypes for breeders, growers, and consumers. In conjunction with the adoption of science-based regulatory practices, there is potential for CRISPR/Cas-mediated gene editing in orphan crop improvement programs to solve a plethora of agricultural problems, especially impacting developing countries. Genome sequencing has progressed, becoming more affordable and applicable to orphan crops. Open-access resources allow for target gene identification and guide RNA (gRNA) design and evaluation, with modular cloning systems and enzyme screening methods providing experimental feasibility. While the genomic and mechanistic limitations are being overcome, crop transformation and regeneration continue to be the bottleneck for gene editing applications. International collaboration between all stakeholders involved in crop improvement is vital to provide equitable access and bridge the scientific gap between the world’s most economically important crops and the most under-researched crops. This review describes the mechanisms and workflow of CRISPR/Cas in planta and addresses the challenges, current applications, and future prospects in orphan crops. Frontiers Media S.A. 2021-09-22 /pmc/articles/PMC8493294/ /pubmed/34630494 http://dx.doi.org/10.3389/fpls.2021.742932 Text en Copyright © 2021 Venezia and Creasey Krainer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Plant Science
Venezia, Matthew
Creasey Krainer, Kate M.
Current Advancements and Limitations of Gene Editing in Orphan Crops
title Current Advancements and Limitations of Gene Editing in Orphan Crops
title_full Current Advancements and Limitations of Gene Editing in Orphan Crops
title_fullStr Current Advancements and Limitations of Gene Editing in Orphan Crops
title_full_unstemmed Current Advancements and Limitations of Gene Editing in Orphan Crops
title_short Current Advancements and Limitations of Gene Editing in Orphan Crops
title_sort current advancements and limitations of gene editing in orphan crops
topic Plant Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493294/
https://www.ncbi.nlm.nih.gov/pubmed/34630494
http://dx.doi.org/10.3389/fpls.2021.742932
work_keys_str_mv AT veneziamatthew currentadvancementsandlimitationsofgeneeditinginorphancrops
AT creaseykrainerkatem currentadvancementsandlimitationsofgeneeditinginorphancrops